12.88 -0.12 (-0.92%) | 03-28 16:00 | |||||||||||||
|
|
Short term | ||||
Mid term | ||||
Targets | 6-month : | 15.81 | 1-year : | 17.66 |
Resists | First : | 13.53 | Second : | 15.11 |
Pivot price | 13.36 | |||
Supports | First : | 10.97 | Second : | 9.13 |
MAs | MA(5) : | 12.98 | MA(20) : | 13.53 |
MA(100) : | 11.23 | MA(250) : | 14.02 | |
MACD | MACD : | 0.1 | Signal : | 0.3 |
%K %D | K(14,3) : | 10.9 | D(3) : | 13.2 |
RSI | RSI(14): 48.6 | |||
52-week | High : | 18.7 | Low : | 8.86 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ RCM ] has closed above bottom band by 20.5%. Bollinger Bands are 19.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
If tomorrow: | Open lower | Open higher |
High: | 13.34 - 13.4 | 13.4 - 13.45 |
Low: | 12.65 - 12.74 | 12.74 - 12.81 |
Close: | 12.76 - 12.89 | 12.89 - 13 |
R1 RCM Inc. provides technology-driven solutions that transform the patient experience and financial performance of hospitals, health systems, and medical groups. It offers end-to-end revenue cycle management (RCM) services, which address the spectrum of revenue cycle challenges faced by healthcare providers. The company also provides modular services, including physician advisory services, which assists healthcare organizations in complying with payer requirements regarding whether to classify a hospital visit as an in-patient or an out-patient observation case for billing purposes; practice management services that offers administrative and operational support for patient care and outsource non-core functions; revenue integrity solutions, including charge capture, charge description master maintenance, and pricing services; coding management services, such as business intelligence and analysis, human capital management, accountability framework, and quality management programs; patient experience; and business office services. In addition, the company offers software-as-a-service based scheduling and patient access solutions. The company was founded in 2003 and is headquartered in Murray, Utah.
Thu, 28 Mar 2024
RCM News Today | Why did R1 RCM stock go up today? - MarketBeat
Wed, 27 Mar 2024
R1 Releases Fourth Annual Environmental, Social and Governance (ESG) Report - GlobeNewswire
Wed, 27 Mar 2024
Public Employees Retirement System of Ohio Has $938000 Stock Holdings in R1 RCM Inc. (NASDAQ:RCM) - Defense World
Mon, 25 Mar 2024
Morgan Stanley maintains Overweight on R1 RCM stock with $17 target - Investing.com
Thu, 21 Mar 2024
R1 RCM Data Breach Lawsuit Investigation - ClassAction.org
Thu, 21 Mar 2024
R1 RCM Data Breach Impacts 16,000 Patients - HIPAA Journal
Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
Exchange:
NASDAQ
|
|
Sector:
Healthcare
|
|
Industry:
Healthcare - Information Services
|
|
Shares Out | 420 (M) |
Shares Float | 292 (M) |
Held by Insiders | 1 (%) |
Held by Institutions | 104 (%) |
Shares Short | 17,490 (K) |
Shares Short P.Month | 27,500 (K) |
EPS | 0 |
EPS Est Next Qtrly | 0 |
EPS Est This Year | 0 |
EPS Est Next Year | 0 |
Book Value (p.s.) | 6.55 |
Profit Margin | 0.1 % |
Operating Margin | 13.3 % |
Return on Assets (ttm) | 3.2 % |
Return on Equity (ttm) | 0.1 % |
Qtrly Rev. Growth | 7.8 % |
Gross Profit (p.s.) | 0 |
Sales Per Share | 5.35 |
EBITDA (p.s.) | 1.29 |
Qtrly Earnings Growth | 0 % |
Operating Cash Flow | 340 (M) |
Levered Free Cash Flow | 326 (M) |
PE Ratio | 1288 |
PEG Ratio | 262 |
Price to Book value | 1.96 |
Price to Sales | 2.4 |
Price to Cash Flow | 15.91 |
Dividend | 0 |
Forward Dividend | 0 |
Dividend Yield | 0% |
Dividend Pay Date | Invalid DateTime. |
Ex-Dividend Date | Invalid DateTime. |